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INTRODUCTION
In  recent  years, o ral contro lled  d rug  
delivery has att racted g reat attent ion in  
pharmaceut ica l fie ld  in o rder to atta in  improved  
therapeut ic ad van tages, such as short e liminat ion  
half life , systemic to xicit ies and pat ient  
co mplian ce so fo rth.1 Nanopart ic les med iated d rug  
delivery red uces the frequen cy o f dos ing in  
therapeut ic cond it ions by sustained d rug release 
and maintains its effect ive d rug co ncentrat ion in  
the syste mic circu lat ion over a longer period o f 
time.2 Even though , the systemic  d rug delivery o f 
nanosystems is in market , o ral d rug delivery is 
important in various clin ical co nd it ions, 
part icu larly gast ro in test inal t ract d iso rders. More 
recent ly , the pursu it and exp lo rat ion o f dev ices 
des igned to be retained d rugs in  the upper part o f 
the gast ro intest inal t rac t ( GIT) has advan ced  
cons istent ly in terms o f tech no logy and d ivers ity, 
enco mpass ing a variety o f b iosystems an d dev ices 
like float ing systems , s welling -expand ing systems, 
bioadhes ive system, modified - shape syste m etc .3
Gast ric retent ion has advan tag es in delivering of 
drug with narrow absorpt ion in the upper part o f 
GIT. A lso , longer residen ce t ime in the stomach  
cou ld be advantageous fo r local act ion in the GIT, 
part icu larly  treatment  o f pept ic ulcer d is eases . 
Gast roretent ive d rug delivery is one o f the 
site spec ific deliveries fo r che motherap eut ic d rugs 
either at stomach o r at int est ine lev el.4 It is  
obtained  by  retain ing dosage fo rm into  stomach  
and d rug is being released at con tro lled man ner to  
spec ific s ite either in sto mach , duodenum and  
in test ine. Naringen in (NRG, 4’, 5, 7- t rihydroxy  
flavanone), a natu rally occu rring flav ono id, and  
ag lycone o f naring in , is widely p resen t in cit rus 
fru its , tomat oes , cherries, grapefru it and  
coco a.5,6,7 ,8,9 It is well known fo r various b io log ical
act ions, such as ant ioxidant , an t i- in flammatory, 
ant i- u lcer, as well as ant i-carcinogen ic effects .10,11
The d rug , Yet it su ffers from b iopharmaceut ical 
rest rict ions due to its poor water so lub ility which  
resu lts in poor absorpt ion and short half life about  
2 hours .12,13 A lso NRG has been  rep orted to  have 
short  d rug  res iden ce t ime in  the stomach .14 So it is  
necessary to dev elop gast ro reten t ive delivery  
system to maintain its integrity .
In the p resent study was an at tempt to  
des ign and fo rmulate NRG- loaded gast ro retent ive 
muco adhes ive po lymeric nanopart ic les us ing  
synthet ic po lymers such as Eudrag it E 100 (EE 
100) an d po lyv iny l a lcoho l (P VA ). The 
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phys ico chemical characterizat ion o f NMPN was 
carried by dyna mic light scattering (DLS), zeta 
poten t ial, load ing effic iency, d rug load ing conten t, 
fourier t rans fo rm in frared spect roscopy (FTIR), 
nuclear mag net ic resonance spectroscopy (1 H 
NMR) and fie ld emiss ion t rans miss ion elect ron  
mic rosco py (FE- TEM) stud ies. The mucoadhes ive 
propert ies were determined by s welling and in  
vit ro mucoadhes ion stud ies. A lso , d rug release in  
stimulat ed gast ric and in test inal flu ids has been  
assessed. The in vivo pharmacokinet ic pattern of 
NMPN was  also  stud ied  in W istar rats. 
MATER IALS  AND METHODS
Eudragit® E 100 (EE 100) was obtained from 
Evonik Industries, Mumbai, India. Naringenin (NRG) 
was purchased from Sigma- Aldrich Chemicals, St. 
Louis, MO., Mumbai, India. While other fine 
chemicals, reagents and solvents used for the 
experiments were of analytical grade, purchased from 
Merck Ltd., Mumbai, India. Milli Q water was used in 
all experiments.
Formulation of NMPN: 15, 16, 17
NMPN were formulated using a 
nanoprecipitation technique with slight modifications. 
The internal organic phase composed of 50 mg NRG 
and 500 mg EE 100 in 25ml of ethanol. This internal 
solution was quickly injected into the 75ml external 
aqueous solution containing 500 mg of PVA , and then 
the solutions were stirred. Then the emulsion was 
ripened at 100 °C for an hour by introducing the 
thermal deco mposition and cooled in an appropriate 
manner. The reaction mixture was purified by 
centrifugation at 6000 rpm to remove small partic les. 
The precipitate was main ly co mposed of nanoparticles. 
It was lyophilized and stored for further use.
Physicochemical characterization Techniques:
DLS analysis of NMPN:
Measurement of partic le size, polydispersity 
index of the free NRG and NMPN was performed by 
Photon Correlation Spectroscopy known as Dynamic 
Light Scattering (Nano- ZS90 - Malvern Instruments). 
Each sample was appropriately diluted 10 fold with 
ultra purified water and measured at 25° C and 90° 
scattering angle, recorded for 180 s. Each value was 
measured in triplicate. The results were showed as mean 
± SD d istribution. Surface charge of the NMPN were 
also characterized with Zeta potential (ζ) using a 
Malvern Nano- ZS90. The measurements were done 
using an aqueous dip cell in an automatic mode by 
placing diluted samples (with ult ra-purified water) in 
the capillary measurement cell and cell position was 
adjusted.
1H Nuclear Magnetic Resonance (1 H NMR): 18
The 1H NMR spectra of free NRG and NMPN 
were recorded using a JEOL Alpha 400 spectrometer. 
An amount of 50 mg of each sample was dissolved in 
1.0 ml of DMSO-d6 and each sample was measured and 
recorded in triplicate.
Fourier Transform Infrared S pectroscopy (FTIR):
Infrared spectra were obtained using a Perkin 
Elmer FTIR spectrometer. In order to collect the 
spectra, a small amount of the compound was used by 
compression in KBr tablets. The IR spectra were 
obtained in the spectral region 400-4000cm-1 using 
resolution 4cm-1 and 10 co-added scans. The spectrum 
of the KBr pellet was used as background. The spectra 
presented were baseline corrected and normalized.
Morphology in Electron Microscopy:
The morphology of the NMPN was observed 
using field emission Scanning electron microscopy (FE-
TEM) (JSM 2100, JEOL, Japan). One drop of properly 
diluted nanoparticles suspension was placed on a silicon 
substrate and air dried under ambient condition to study 
the morphology at various magnifications.
Loading Efficiency of NMPN: 19
Loading effic iency of NRG was determined 
after the twice centrifugation at 12,000 rpm and 4 °C for 
25min. The amount of free NRG was determined in 
clear supernatant by Schimad zu UV 1800 
spectrophotometer with the detection wavelength of 262 
nm. The following equation were applied to calculate 
the loading effic iency (%) = [(WO – Wt) / WO] X 100. 
WO and Wt are the weight of initial concentration of 
NRG and that of the total amount of NRG detected in 
supernatant after twice centrifugation respectively. Each 
sample was assayed in triplicate.
Evaluation of Mucoadhesive property:
Swelling Study: 20
The swelling studies on NMPN were 
performed with 0.1N HCl (pH 1.2) and phosphate 
buffer (pH 7.4). In brief, 100 mg of NMPN accurately 
weighed and immersed in 0.1N HCl and phosphate 
buffer, and kept for 24 hrs. The swelling index (SI) was 
calculated by using the following formula: SI = (W i –
Ws/ Ws) X 100. Where SI= percentage of swelling of 
nanoparticles, Wi = in itia l weight of nanoparticles, and 
Ws = weight of nanoparticles after swelling. 
In-vitro mucoadhesion studies: 21
Naringenin- loaded gastroretentive 
mucoadhesive polymeric nanoparticles were immersed 
in a 50 ml glass beaker at 37 °C containing a 0.1N HCl
(pH 1.2). Fresh rat gastric mucosa was cut into 2 X 3cm 
and was placed on nanoparticles surface. Gastric  
mucosa was removed after 30 min and mucosa with the 
attached nanoparticles were removed and the remaining 
particles on the glass beaker were dried at 60 °C till 
constant weight. Percent of adhered nanoparticles (AN) 
was estimated using the following equation: AN (%) = 
(Wo – Wr/ Wo) X 100. Where, Wo is the initial weight 
of nanoparticles and Wr the remained unattached 
weight of nanoparticles.
In vitro release studies:
The in vitro drug release studies were 
conducted in stimulated gastric fluid (pH 1.2) and 
stimulated intestinal fluid (pH 6.8). An appropriate 
amount of NMPN was placed in a beaker containing 50
ml of simulated gastric fluid and intestinal fluid at 37 
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°C with shaking conditions. 0.1 ml of flu id was 
withdrawn at  each time point periodically and replaced 
with the same volume of fresh fluid and the amount of 
drug was quantified by HPLC analysis.
Evaluation of Pharmacokinetic Profile:
Animals and Dosing: All the animal study protocols 
were duly approved by the Institutional Animal Ethics 
Committee, India. Male Wister strain rats weighing 
200-250 g were maintained in controlled room 
temperature (20°C ± 2°C) and relative humidity (60% ± 
10%) on 12 hrs light/dark cycle. Water and commercial 
laboratory complete food for rats were available ad
libitum. They were acclimat ized to this environment for 
7 days before receiving experimental treat ment. The 
animals were randomly distributed into two groups each 
containing six animals. Different groups of animals 
received oral dose of free NRG (20 mg/ kg) and NMPN 
(20 mg/ kg). Blood samples (approximately 0.5ml) were 
collected at periodic time intervals (0, 4, 8, 12, 16, 20 
and 24 hrs) from the retro- orbital plexus. After each 
sampling, 1ml of dextrose- normal saline was 
administered orally to prevent changes in the central 
compartment volume and electrolytes. Plasma was 
separated by centrifuging the blood samples at 10,000 
rpm for 10 min at 4 °C and kept at – 80 °C until 
analyzed.
Determination of naringenin in rat plasma by 
HPLC:
Naringenin in rat p lasma was analyzed by 
HPLC using a mixture of acetonitrile and 2% acetic  
acid in a volume ratio of 51:49 (v/v) as the mobile
phase at a flow rate of 1.0 ml ⋅ minute−1. For the 
measurement of plasma NRG, 50 μ l of internal standard 
solution (hesperitin, 4 μg ⋅ ml−1 in ethanol) was added 
to 0.2 ml plasma. After vortex mixing for 1 min, 500 μl
of anhydrous diethyl ether was added and again vortex-
mixed for 1 min. After centrifugation at 10,000 rpm for 
10 min, the supernatant was withdrawn and evaporated 
under a light stream of nitrogen at room temperature. 
The residue was dissolved in 100 μ l of the mobile phase 
and again centrifuged at 10,000 rpm for 10 min. 20 μl
of the supernatant was then injected for HPLC analysis. 
Quantificat ion was based on the peak area ratio R 
(ACUR/AEMO). The calibration curve obtained was R 
= 0.0023C + 0.0335 (r = 0.9998, n = 5), with a 
correlation coefficient 0.999. The pharmacokinetic  
parameters of free NRG as well as NMPN groups were 
calculated by using noncompartmental method. The 
area under the curve and the mean residence time were 
determined by standard methods applying the linear 
trapezoidal rule . 
STATISTICAL ANALYS IS
GraphPad Pris m 5 software was used for 
statistical analysis (GraphPad Software Inc., San Diego, 
USA). Data are expressed as mean ± SD. Data were 
analyzed by one-way analysis of variance (ANOVA)
followed by the Student–Newman–Keul multiple 
comparison test. Differences were considered 
significant at P< 0.05.
RES ULTS AND DISCUSS ION:
NMPN were formulated by a simple 
nanoprecipitation method with thermal decomposition 
approaches. Nanoprecipitation is a simplistic and mild 
process technique for the preparation of nano scale 
compounds and it was one of the most superior to other 
encapsulation methods.22 During the particle synthesis 
both internal phases of NRG and EE 100 are 
hydrophobic in nature interacts each other and form a 
suspension. These internal phase suspension was 
introduced into external aqueous phase and produce 
interfacial tension to form stronger outer surface with 
the help of PVA as a stabilizer. Nanoprecipitat ion was 
conducted through the precipitation of a performed 
polymer from an organic solution which was previously 
solubilized, with the diffusion of this organic solvent 
into the aqueous medium. In the aqueous phase, the 
polymers get insoluble, prec ipitating immediately 
leading to the format ion of nanoparticles.23 In addition 
to that under thermal decomposition by means of the 
mixtu re face above melting temperature and it was 
cooled very slowly to form crystals which results in the 
formulat ion of cubic partic les.24,25,26
Figure 1a showed the mean particle size 
distribution of the formulated nanoparticles. 
Nanoparticles size is a useful parameter since its affects 
the drug loading and release. The size distribution of the 
formulated NMPN was smaller with narrow 
distributions. The magnitude of the zeta potential on the 
NMPN was relat ively high due to their stronger 
electrostatic repulsion that inhibits the particle 
aggregation 27 that showed in Figure 1b. 
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(a) (b)
Figure 1: The Graphica l representation of (a) mean particle size; (b) zeta potential of formulated naringenin- loaded 
gastroretentive mucoadhesive polymeric  nanoparticles.
Formulated NMPN were characterized by 1H 
NMR and FTIR, the hydrogen bonding of free NRG as 
well as NMPN were showed in Figure 2. Hydrogen 
bonding formation can be accounted by chemica l shift 
changes in compound.28,29 The spectrum of free NRG 
showed protons on aromatic groups ranging from H6 –
H8 (6.77- 6.79ppm) and strong intra molecular 
hydrogen bonding at 12.14ppm. Where NMPN showed 
that the aromatic protons were shifted and the intra 
molecular hydrogen bonding disappeared. 
The spectrum of NMPN showed protons on 
aromat ic group from H6 – H8 was shifted to about 
0.1ppm. In frared spectroscopy was used to study the 
interactions between the drug and the polymers that 
showed in Figure 3. Functional characteristics peak for 
drug in the region of   3849cm-1. An FTIR spectrum of 
NMPN does not have a characteristic peak indicating 
that drug had been loaded into nanoparticles. NMPN 
spectra did not show any changes in characteristic peaks 
for EE-100 and PVA in the region of 1390-1370cm-1
and 1407cm-1 respectively, its indicating that polymer 
and stabilizer inter connected with outer layer in 
nanostructure. 
Figure 2: 1H NMR spectrum of (a) free NRG and (b) NMPN dissolved in DMSO- d6.
b
a
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Figure 3: Infrared spectrum of indiv idual compounds NRG, EE 100, PVA and NMPN.
Figure 4: FE- TEM micrograph of formulated NMPN at various magnificat ions.
Nanoparticles morphology was shown in 
Figure 4. The particles had a cubic morphology with a 
smooth surface with no polymeric aggregates. Particles 
are smaller in size, among most of them are similar in 
dimensions. Hydrodynamic process takes place during 
the particle preparation which leads to the higher 
loading effic iency of NRG in surrounding aqueous 
phase. When adjusting the proportion of stabilizer 
(PVA ) in aqueous phase that influencing the loading 
efficiency of NRG. The possible reason was the 
hydrophobic nature of EE 100 interpenetrates into the 
hydrophilic nature of PVA during particle preparation 
and remained that trapped to the matrix structure. 
The loading efficiency of NMPN was showed 
in Table 1. Hydrodynamic process takes place during 
the particle preparation which leads to the higher 
encapsulation of NRG in surrounding aqueous phase. 
The hydrophobic nature of EE 100 interpenetrates into 
the hydrophilic nature of PVA during particle  
preparation and remained that trapped to the matrix 
structure.  
Table 1: Determination of mean particle size, zeta potential, poydispersity index (PDI) and loading efficiency of blank 
Nanoparticles (NP) and formulated NMPN (mean ± SD, n = 3).
Nanoparticles Size (nm) Zeta Potential (mv) PDI Loading effic iency (%)
Blank NP 62.4 – 25 ± 1.3 0.20 ± 0.027 ---
NMPN 66.7 – 34 ± 0.64 0.22 ± 0.019 89.4 ± 2.41
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The pH is one of the major factors that 
significantly influence the swelling behavior of a 
system. The pH responsive system has been most 
frequently used to design controlled release 
formulat ions for oral ad min istration of drug, which 
remains the most clinically acceptable way of drug 
delivery. 30 The present study the effect of pH on the 
swelling behavior of NMPN was investigated at pH of 
1.2 and 7.4 which represents the pH conditions of 
stomach and blood respectively. The swelling results 
are shown in Figure 5 which indicates a significant faith 
of swelling behavior of the NMPN on different pH 
concentrations. The results revealed at pH 1.2, a h igher 
swelling ratio was found when compared to pH 7.4 
which is due to the mucoadhesive polymer used for the 
preparation of nanoparticles. Mucoadhesive studies had 
been done in order to assess the adhesion of NMPN on 
gastric mucosal membrane. NMPN shows satisfactory 
adhesion property which is due to the mucoadhesive 
polymer used. Mucoadhesive property of EE 100 are  
mostly dependent on the ionic interaction of positively 
charged amine group of EE 100 with negatively 
charged ions present within mucus membrane of 
sulfonic acid and sialic acid residues.
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Figure 5: Swelling profile of NMPN at pH 1.2 and 7.4. Indicated values are the mean of three measurements (mean ± 
SD, n= 3).
The release profile of NMPN in stimulated gastric and 
intestinal fluids showed in Figure 6 (a & b). Eudragit E 
100 is a copolymer o f methacrylic ac id and ethyl 
acrylate that soluble below the pH of 4.5. It should 
therefore be possible to design polymeric system that 
loaded and protect bioactive compounds within acidic 
environments (site specific, stomach). We therefore 
investigated the release of NRG from NMPN. In NMPN 
the drug was released up to 24 hrs in stimulated gastric 
flu id thus indicating long acting controlled release with 
high precision. Therefore the prolonged release pattern 
of NRG which might contributes to reduce the frequent 
dose and enhances the drug absorption. 31
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Figure 6: In vitro release profile of free NRG and NMPN in (a) stimulated gastric fluid (pH 1.2) and (b) stimulated 
intestinal flu id (pH 6.8) at various time intervals (mean ± SD, n = 3).
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Figure7: Plas ma concentration- time profile o f free NRG and NMPN after oral ad ministration of 20 mg/ kg body 
weight in rats (mean ± SD, n = 6).
The plasma concentration time profile of free 
NRG and NMPN showed in Figure 7. Main 
pharmacokinetics parameters in plas ma as well as 
stomach tissue homogenate following a single  oral 
administration of 20mg/ kg body weight in rats showed 
in Table 2. NMPN is well absorbed due to the 
controlled release in ac idic media without degradation 
of the drug when compared with the free NRG. The 
pharmacokinetic parameters AUC and MRT show 
significant differences between free  NRG and NMPN in 
plasma and stomach tissue homogenate. Longer 
residence time in stomach tissue homogenate allows 
more active components to penetrate through the gastric 
mucus membrane and to be absorbed above the 
absorption zone.31 Therefore, the formulated NMPN are 
suitable for stomach specific delivery. 
Table 2: Main pharmacokinetics parameters following a single oral dose administration of free NRG and NMPN 20
mg/ kg body weight in rats (mean ± SD, n = 6).
Groups AUC (ng h/ml) MRT (h)
Plasma
Free NRG 4523.71 ± 21.5 3.85 ± 0.84
NMPN 2158.29 ± 17.3 2.10 ± 0.52
Stomach Tissue
Free NRG 2710.48 ± 28.4 1.80 ± 0.35
NMPN 9776.53 ± 25.6 16.58 ± 1.08
AUC – area under the curve; MRT – mean residence time
CONCLUS ION
The naringenin- loaded gastroretentive 
mucoadhesive polymeric nanoparticles has been 
formulated by a facile nanoprecipitation method under 
thermal decomposition. The formulated NMPN have 
been smaller in size with higher stability and higher 
drug loading efficiency. The morphology was 
evidenced by FE-TEM and functional characteristics 
were confirmed by FTIR and 1H NMR. The Sustained 
drug release of NRG was prolonged up to 24 hrs in 
stimulated gastric fluid. Swelling and mucoadhesion 
studies demonstrated that NMPN exhib ited good 
mucoadhesive in nature. Thus the results of the present 
study were suggested that the NMPN was found to be a 
sustained drug delivery vehicle with prolonged release 
when injected in the form of o ral delivery. 
Pharmacokinetic fate was investigated in NMPN, they 
have a site specific delivery in stomach due to increased 
AUC and residence time as compared to free NRG. 
Further, the toxicity will be assessed in vitro and in vivo
tumor models, in order to explore its therapeutic 
efficacy in the field of biomedical application.
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